LTS:0SAN (Switzerland)
Â
Registered Shares
CHF
71.71
-0.27 (-0.38%)
Jul 3
Business Description
Sandoz Group AG
ISIN : CH1243598427
Share Class Description:
LTS:0SAN: Registered SharesTotal Employee Number:
23,000Compare
Compare
Traded in other countries / regions
SDZ.Switzerland0SAN.UKSDZNY.USAD8Y.GermanySDZN.MexicoSDZ.Austria IPO Date
2023-10-10Description
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 2.86 | |||||
Interest Coverage | 6.47 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.65 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.4 | |||||
3-Year EBITDA Growth Rate | -0.4 | |||||
3-Year EPS without NRI Growth Rate | 15.9 | |||||
3-Year FCF Growth Rate | -4.9 | |||||
3-Year Book Growth Rate | -3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.72 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.46 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.15 | |||||
9-Day RSI | 61.5 | |||||
14-Day RSI | 62.71 | |||||
3-1 Month Momentum % | -1.44 | |||||
6-1 Month Momentum % | 8.77 | |||||
12-1 Month Momentum % | 47.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 187.03 | |||||
Days Sales Outstanding | 79.24 | |||||
Days Payable | 109.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.12 | |||||
Dividend Payout Ratio | 0.2 | |||||
Forward Dividend Yield % | 1.12 | |||||
5-Year Yield-on-Cost % | 1.12 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.26 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 47.35 | |||||
Operating Margin % | 12.76 | |||||
Net Margin % | 8.18 | |||||
EBITDA Margin % | 17.67 | |||||
FCF Margin % | 7.23 | |||||
OCF Margin % | 14.25 | |||||
ROE % | 10.05 | |||||
ROA % | 4.17 | |||||
ROIC % | 6 | |||||
3-Year ROIIC % | 1.33 | |||||
ROC (Joel Greenblatt) % | 53.33 | |||||
ROCE % | 9.43 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 43.09 | |||||
Forward PE Ratio | 22.05 | |||||
PE Ratio without NRI | 24.74 | |||||
PS Ratio | 3.52 | |||||
PB Ratio | 4.19 | |||||
Price-to-Free-Cash-Flow | 48.75 | |||||
Price-to-Operating-Cash-Flow | 24.73 | |||||
EV-to-EBIT | 30.07 | |||||
EV-to-Forward-EBIT | 17.53 | |||||
EV-to-EBITDA | 21.75 | |||||
EV-to-Forward-EBITDA | 13.87 | |||||
EV-to-Revenue | 3.84 | |||||
EV-to-Forward-Revenue | 3.17 | |||||
EV-to-FCF | 53.18 | |||||
Earnings Yield (Greenblatt) % | 3.33 | |||||
FCF Yield % | 2.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sandoz Group AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 8,976.833 | ||
| EPS (TTM) (CHF) | 1.679 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 24.7 | ||
| 14-Day RSI | 62.71 | ||
| 14-Day ATR (CHF) | 1.876085 | ||
| 20-Day SMA (CHF) | 69.275691 | ||
| 12-1 Month Momentum % | 47.6 | ||
| 52-Week Range (CHF) | 42.565 - 74.7 | ||
| Shares Outstanding (Mil) | 432.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sandoz Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sandoz Group AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 09:00 | In 118 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 117 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 31 days | ||
| CHF 0.800000 Cash Dividend | 2026-04-13 | 66.62 (+2.33%) | ||
| General meeting for 2026 | 2026-04-09 | 65.12 (+0.30%) | ||
| Jefferies Pan-European Mid-Cap Conference | 2026-03-25 | 59.38 (-0.73%) | ||
| BNP Paribas Exane Healthcare Conference | 2026-03-24 | 57.96 (+0.03%) | ||
| Bank of America Pharma Bus Tour | 2026-03-12 | 61.22 (-2.83%) | ||
| Barclays Global Healthcare Conference | 2026-03-10 | 62.04 (-0.03%) | ||
| Guidance call for 2025 | 2026-03-03 | 67.86 (+0.83%) |
Show
Entries
Sandoz Group AG Frequently Asked Questions
What is Sandoz Group AG(LTS:0SAN)'s stock price today?
The current price of LTS:0SAN is CHF71.71. The 52 week high of LTS:0SAN is CHF74.70 and 52 week low is CHF42.57.
When is next earnings date of Sandoz Group AG(LTS:0SAN)?
The next earnings date of Sandoz Group AG(LTS:0SAN) is 2026-08-05.
Does Sandoz Group AG(LTS:0SAN) pay dividends? If so, how much?
The Dividend Yield %  of Sandoz Group AG(LTS:0SAN) is 1.12% (As of Today), Highest Dividend Payout Ratio of Sandoz Group AG(LTS:0SAN) was 0.2. The lowest was 0.18. And the median was 0.19. The  Forward Dividend Yield % of Sandoz Group AG(LTS:0SAN) is 1.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sandoz Group AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers